Cytological versus serological diagnosis of Herpes Simplex Virus type 2 infection among women with cervicitis without external genital ulcer or blistering lesions in Hawler Maternity Teaching Hospital

Katan Sabir Ali; Yusra Abdulkhaliq Qasim

doi:10.15218/zjms.2014.0035

Authors

Katan Sabir Ali Department of Pathology, College of Medicine, Hawler Medical University, Erbil, Iraq
Yusra Abdulkhaliq Qasim Department of Pathology, College of Medicine, Hawler Medical University, Erbil, Iraq

DOI:

https://doi.org/10.15218/zjms.2014.0035

Keywords:

Pap smear, Herpes simplex virus type 2

Abstract

Background and objective: Herpes simplex virus type 2 linked to the genital tract infection may produce significant acute or chronic cervicitis. Identification of the virus is important due to its association with genital tract disease and sexual transmission. The virus establishes lifelong latency with periodic reactivation. Therefore, it causes significant physical and psychological morbidity. The aim of this study was to assess and compare cytological examination with serological test in the diagnosis of genital herpes simplex virus type 2.

Methods: This study included 104 women. Pap smear was collected from 24 healthy women as a control group (group A), 40 patients with severe cervicitis on cytological examination (group B) and 40 patients with atypical cervicitis (group C). Blood sample was obtained from the patients and the control group and tested for Herpes simplex virus type 2 specific serology. The ages of the studied groups ranged from 21-53 years. They were referred to the Maternity Teaching Hospital and private laboratories in Erbil city, Kurdistan region, Iraq during the period from December 2011 to December 2012.

Results: Herpes simplex virus type 2 IgG antibodies were found in 10 sera from patients with nonspecific cervicitis (group-B) and only in three patients with atypical cervicitis (group-C). No positive serological test was identified in the control group. All Pap smear results showed features suggestive of cervicitis but without viral cytopathic herpetic changes.

Conclusion: The serological test was superior to cytology for the diagnosis of Herpes simplex virus type 2 infection in women presented with cervicitis with no clinically apparent genital ulcer or blisters.

Metrics

Metrics Loading ...

References

Gardella C. Herpes simplex virus genital infections: current concepts. Curr Infect Dis Rep 2011; 13(6):588-94.

Kumar V, Abbas AK, Fausto N, Aster JC. Infection of the female genital tract. In:Kumar V, Abbas AK, Fausto N, Aster JC, Editors. Robbins and Cotran Pathologic basis of disease. 8th Edition. Philadelphia: Saunders; 2010. P. 1008-9.

Wutzler P, Doerr HW, Färber I, Eichhorn U, Helbig B, Sauerbrei A, et al. Seroprevalence of Herpes Simplex Virus Type 1 and Type 2 in Selected German Populations Relevance for the Incidence of Genital Herpes. J Med Virol 2000; 61(2):201-7.

Duran N, Yarkin F, Evruke C, Koksal F. Asymptomatic herpes simplex virus type 2 infection among pregnant women in Turkey. Indian J Med Res 2004; 120(2):106-10.

Ashley RL. Laboratory techniques in the diagnosis of herpes simplex infection. Genitourinary Med1993; 69(3):174-83.

Gupta R, Warren T, Wald A. Genital herpes. Lancet 2007; 370(9605):2127-37.

Shin HS, Park JJ, Chu C, Song HJ, Cho KS, Lee JS, et al. Herpes simplex virus type 2 seroprevalence in Korea: rapid increase of HSV-2 seroprevalence in the 30s in the southern part. J Korean Med Sci 2007; 22(6):957-62.

Money D, Steben M. Infectious Diseases Committee, Society of Obstetricians and Gynecologists of Canada. Guidelines for the management of herpes simplex virus in pregnancy. J ObstetGynaecol Can 2008; 30(6):514-26.

Richard JW, Stephen KT, Lisa MH, Stephen AB. Emerging Issues in the Management of herpes simplex virus Infections. Johns Hopkins Advanced Studies in Medicine 2006; 6 (10F): 1092-103.

Brown ZA, Wald A, Morrow RA, Selke S, Zeh J, Corey L. Effect of serological status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 2003; 289: 203-9.

Bolan G. California guidelines for the use of herpes simplex type 2 serology tests. Medical Board of California Action Report. April 2004; 10-2. www.cdph.ca.gov/healthinfo/.

Watanabe D. Medical application of herpes simplex virus. J Dermatol Sci 2010; 57(2):75-82.

Rattray MC, Corey L, Reeves WC, Vontver LA, Holmes KK. Recurrent genital herpes among women: symptomatic versus asymptomatic viral shedding. Br J Vener Dis 1978; 54(4):262-5.

Langenberg AGM, Corey L, Ashley RL, Leong WP, Stephen E. A prospective study of new infection with herpes simplex infection type 1 and type 2. N Engl J Med 1999; 341:1432 -8.

Munday PE, Vuddamalay J, Slomka MJ, Brown DW. Role of type specific herpes simplex virus serology in the diagnosis and management of genital herpes. Sex Transm Infect 1998; 74(3):175-8.

Haverkos H, Rohrer M, Pickworth W. The cause of invasive cervical cancer could be multifactorial. Biomed Pharmacother 2000; 54(1):54-9.

Calvet HM. Sexually transmitted diseases other than human immunodeficiency virus infection in older adults. Clin Infect Dis 2003; 36(5):609–14.

Paulo M, Borges AB, Duarte G, Quintana SM, Montes MB, Toloi MR. The environmental cofactors in carcinogenesis in high risk HPV/HIV-positive women. Braz J Infect Dis 2007; 11(2):189-95.

Tran-Thanh D, Provencher D, Koushik A, Duarte-Franco E, Kessous A, Drouin P, et al. Herpes simplex virus type II is not a cofactor to human papillomavirus in cancer of the uterine cervix. Am J Obstet Gynecol 2003; 188(1):129-34.

Chan J KC, Arber DA, Brunning RD, Desmet VJ, Demasters BK, Rosenblum MK et al. Cervix. In: Chan J KC, Arber DA, Brunning RD, Desmet VJ, Demasters BK, Rosenblum MK et al,Editors. Rosai and Ackerman's Surgical Pathology. 10th Edition.New York.USA: Mosby Elsevier; 2011. P. 1457-59.

Marisa RN, Christopher PC. The Cervix. In: Mills SE, Carter D, Greenson JK, Reuter VE and Stoler MH, Editors. Sternberg Diagnostic Surgical Pathology. 5th Edition. Baltimore, USA: Lippincott Williams and Wilkins; 2010. P. 2132-33.

Koss LG, Melamed MR. Benign disorders of uterine cervix and vagina. In: Koss LG, Melamed MR, Editors. Koss' diagnostic cytology and its histopathologic bases. 2006.5th Edition. Philadelphia, USA:Lippincott Williams and Wilkins; P. 269-271.

Gun-Britt L, Matilda B, Ellen B, Petra T, Ingela K. Acceptance and Outcome of Herpes Simplex Virus Type 2 Antibody Testing in Patients Attending an STD Clinic – Recognized and Unrecognized Infections. Acta Derm Venereol .2005; 85: 248–252.

Naib ZM, Nahmias AJ, Josey WE, Zaki SA. Relation of cyto-histopathology of genital herpes virus infection to cervical anaplasia. Cancer Res 1973; 33(6):1452-63.

McMillan A .The detection of genital tract infection by Papanicolaou-stained tests. Cytopathology 2006; 17(6):317-22.

Lehtinen M, Hakama M, Aaran RK, Aromaa A, Knekt P, Leinikki P, et al. Herpes simplex virus type 2 infection and cervical cancer: a prospective study of 12 years of follow-up in Finland. Cancer Causes Control 1992; 3(4):333-8.

Nahmias AJ, Naib ZM, Josey WE, Franklin E, Jenkins R. Prospective studies of the association of genital herpes simplex infection and cervical anaplasia. Cancer Res 1973; 33(6):1491-7.

Johnston C, Magaret A, Selke S, Remington M, Corey L, Wald A. Herpes simplex virus viremia during primary genital infection. J Infect Dis 2008; 198(1):31-4.

Jean-Elie M. Epidemiology of Genital Herpes Simplex Virus Infection in Developed Countries. Herpes 2004; IISuppl 1:2A-23A.